Start Date: 26/09/2017

End Date: 27/09/2017

Cost: please see website

Venue: Murray Edwards College, Cambridge, UK

Organiser:

Biotexcel in partnership with: Dr Steve Abbs, Cambridge University Hospitals; Prof Eamonn Maher, University of Cambridge; East of England Genomic Medicine Centre

Contact Details:

https://biotexcel.com/event/genomic-medicine-2017-cambridge/

 

Comments:

The scientific theme for this meeting like most Biotexcel meetings will cover the areas where Next Generation Sequencing is used in the analysis of human disease. These topics will include different disease areas where particularly promising genomic studies have been performed; large population studies such as the East London Genes & health project; whole genome & whole exome studies; epigenomics and many other topics. In a slight variation to our usual back to back academic talks, in this meeting we will also hear from commercial genomic companies, whether those that currently have genomic solutions on the market, or those that are spin-outs or in the research or earlier phases, as well as hearing from Illumina’s Chief Scientist David Bentley. We are excited to have some great names from the world of genomics such as Prof Carlos Caldas, Prof Stephan Beck, Prof Eamonn Maher and many others. Join us in Cambridge for a really exciting meeting where you can hear from the opinion leaders in Genomics in a relaxed casual setting and network with the speakers as well as with other fellow delegates. The evening will see a networking dinner at Thaikhun restaurant where speakers and delegates can meet up and carry on discussions in an even more informal setting.

Link: https://biotexcel.com/event/genomic-medicine-2017-cambridge/

    Latest News

  • ClinGen/ACGS collaboration

    posted 5th February 2018  |  0 Comments

    Association for Clinical Genomic Science (ACGS) has entered into a formal affiliation with the ClinGen Inherited Cardiomyopathy Expert Panel (CMP-EP). We will be working jointly to adapt the ACMG/AMP variant classification guidelines for genes associated with hypertrophic cardiomyopathy (HCM). This work is an extension of the ClinGen CMP-EP's recommendations for MYH7 variant classification. ClinGen and ACGS have a shared goal of developing standardised genomic variant interpretation guidelines for improved patient care. The contribution of genomic and phenotypic data from both groups, as well as collaboration in the decision-making process, represents a first step in global development, acceptance, and use of a common set of specified guidelines.

    Read more